Medtronic Financial Ratios
NYSE: MDTHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Medtronic ratio analysis
Medtronic earned a net margin of 13.2% in FY 2026, down from 13.9% a year earlier. Gross margin was 65.0% compared with a median of 67.4% over the prior 9 years. Return on equity reached 9.7%, meaning Medtronic generated 0.10 dollars of profit for every dollar of shareholders' equity.
Debt-to-equity stood at 0.57 versus 0.59 the year before, and the current ratio was 2.13. At the end of FY 2026, MDT traded at 22.3 times earnings; across the 10 fiscal years shown, its year-end P/E ranged from 22.3 to 49.2, with a median of 28.4. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
Medtronic financial ratios (annual)
| Ratio | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E ratio (at fiscal year end) | 22.34 | 23.31 | 28.89 | 32.25 | 27.98 | 49.22 | 28.05 | 25.62 | 35.81 | 28.75 |
| Price / sales | 2.94 | 3.23 | 3.27 | 3.87 | 4.42 | 5.85 | 4.60 | 3.85 | 3.68 | 3.86 |
| Price / book | 2.16 | 2.25 | 2.11 | 2.35 | 2.67 | 3.42 | 2.62 | 2.35 | 2.17 | 2.28 |
| Gross margin | 65.0% | 65.3% | 65.3% | 65.7% | 68.0% | 65.2% | 67.4% | 70.0% | 69.8% | 68.7% |
| Operating margin | 17.8% | 17.8% | 15.9% | 17.6% | 18.2% | 14.9% | 16.6% | 20.5% | 22.2% | 18.1% |
| Net margin | 13.2% | 13.9% | 11.4% | 12.0% | 15.9% | 12.0% | 16.6% | 15.2% | 10.4% | 13.6% |
| Free cash flow margin | 14.9% | 15.5% | 16.1% | 14.7% | 18.9% | 16.2% | 20.8% | 19.2% | 12.1% | 18.9% |
| Return on equity (ROE) | 9.7% | 9.7% | 7.3% | 7.3% | 9.6% | 7.0% | 9.4% | 9.2% | 6.1% | 8.0% |
| Return on assets (ROA) | 5.2% | 5.1% | 4.1% | 4.1% | 5.5% | 3.9% | 5.3% | 5.2% | 3.4% | 4.0% |
| Debt / equity | 0.57 | 0.59 | 0.50 | 0.47 | 0.46 | 0.51 | 0.49 | 0.51 | 0.51 | 0.67 |
| Current ratio | 2.13 | 1.85 | 2.03 | 2.39 | 1.86 | 2.65 | 2.13 | 2.59 | 2.28 | 1.74 |
| Revenue growth | 8.4% | 3.6% | 3.6% | -1.4% | 5.2% | 4.2% | -5.4% | 2.0% | 0.8% | 3.0% |
| EPS growth | 3.3% | 30.8% | -2.1% | -24.4% | 40.2% | -24.9% | 3.8% | 50.2% | -21.5% | 16.5% |